Advertisement
Home »

Q&A: Optimizing Acute Migraine Treatment Increases Productivity by More Than 50%

Oct 03, 2023

REFERENCES & ADDITIONAL READING

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine

https://journals.lww.com/joem/Fulltext/2023/04000/Optimized_Acute_Treatment_of_Migraine_Is.22.aspx

ABOUT THE EXPERTS

  • Richard B. Lipton, MD

     

     

     

     

     

     

     

     

    Dawn C. Buse, PhD

     

     

     

     

     

     

     

    Aubrey Manack Adams, PhD

     

     

     

     

     

     

     

     

     

    Aubrey Manack Adams, PhD, has indicated to Physician’s Weekly that she is an employee of AbbVie and may hold stock in the company. Dawn C. Buse, PhD, has indicated to Physician’s Weekly that she serves as a consultant or advisory board member to, and receives honoraria or research support from, AbbVie/Allergan, Amgen, Biohaven, Colleguium, Eli Lilly and Company, Lundbeck, and Teva. Richard B. Lipton, MD, has indicated to Physician’s Weekly that he receives research grants from Amgen, Satsuma, and Teva; holds stock and stock options in Biohaven Holdings and stock options in Manistee; serves as consultant or advisory board member, or has received honoraria from AbbVie (Allergan), Amgen, Avanir, Axsome, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s (Promius), Electrocore, Eli Lilly and Company, eNeura Therapeutics, Equinox, GlaxoSmithKline, Grifols, Lundbeck (Alder), Merck, Pernix, Pfizer, Satsuma, Supernus, Teva, Trigemina, Vector, and Vedanta; and receives royalties from Wolff’s Headache 7th and 8th Edition (Oxford Press University, 2009; Wiley and Informa).

Advertisement

MEETING BRIEFS

Advertisement